10-Q/A · 2026-11-18
Invech Holdings, Inc. files an amended quarterly report for Q2 2026, emphasizing transparency and compliance in the management consulting services industry.
| Name | Invech Holdings, Inc. |
|---|---|
| CIK | 0001009919 |
| Tickers | IVHI |
| Exchanges | OTC |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 8742 Services-Management Consulting Services |
| EIN | 414348617 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | NV NV |
| Phone | 725-200-0178 |
| Website | — |
| Investor website | — |
| Owner org | 07 Trade & Services |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Invech Holdings, Inc. files an amended quarterly report for Q2 2026, emphasizing transparency and compliance in the management consulting services industry.
202 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-18 | 10-Q/A | AMENDMENT NO. 2 | 0001683168-26-008922 | 000-25553 | 261568626 | 34 | 3153175 | 1 | 1 | |
| 2026-11-16 | NT 10-Q | 10-Q EXTENSION FOR SEP 2026 | 0001683168-26-008823 | 000-25553 | 261558935 | 34 | 22565 | |||
| 2026-09-15 | 8-K | CURRENT REPORT | 5.01,5.02,9.01 | 0001683168-26-007139 | 000-25553 | 261379691 | 34 | 322917 | 1 | 1 |
| 2026-08-21 | 10-Q/A | FORM 10-Q FOR JUNE 2026 | 0001683168-26-006661 | 000-25553 | 261305773 | 34 | 2357839 | 1 | 1 | |
| 2026-08-12 | 10-Q | FORM 10-Q FOR JUNE 2026 | 0001683168-26-006245 | 000-25553 | 261265816 | 34 | 2309233 | 1 | 1 | |
| 2026-08-04 | 4 | xslF345X06/ownership.xml | 0001683168-26-005938 | 7974 | ||||||
| 2026-08-04 | SC 14F1 | FORM SC 14F1 | 0001683168-26-005933 | 005-78743 | 261237275 | 34 | 48190 | |||
| 2026-08-03 | 8-K | FORM 8-K | 1.01,2.01,5.01,5.02,9.01 | 0001683168-26-005918 | 000-25553 | 261232295 | 34 | 301350 | 1 | 1 |
| 2026-07-10 | 3 | xslF345X06/ownership.xml | 0001683168-26-005446 | 5865 | ||||||
| 2026-06-04 | 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 1.01,2.01,9.01 | 0001683168-26-004546 | 000-25553 | 261063629 | 34 | 203483 | 1 | 1 |
| 2026-06-04 | 8-K | CURRENT REPORT | 1.01,9.01 | 0001683168-26-004544 | 000-25553 | 261063597 | 34 | 198628 | 1 | 1 |
| 2026-05-12 | 10-Q | FORM 10-Q FOR MARCH 2026 | 0001683168-26-003707 | 000-25553 | 26967383 | 34 | 2133815 | 1 | 1 | |
| 2026-04-23 | 8-K | CURRENT REPORT | 1.01,2.01,3.02,8.01,9.01 | 0001683168-26-003159 | 000-25553 | 26889120 | 34 | 242091 | 1 | 1 |
| 2026-04-10 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001155 | 333-294854 | 26856326 | 33 | 2060 | ||
| 2026-04-08 | CORRESP | filename1.htm | 0001683168-26-002744 | 6566 | ||||||
| 2026-04-08 | UPLOAD | filename1.pdf | 0000000000-26-003515 | 333-294854 | 40363 | |||||
| 2026-04-02 | S-1 | REGISTRATION STATEMENT | 0001683168-26-002615 | 333-294854 | 26834022 | 33 | 2073836 | 1 | 1 | |
| 2026-03-31 | 8-K | FORM 8-K | 5.03,8.01,9.01 | 0001683168-26-002471 | 000-25553 | 26818597 | 34 | 494064 | 1 | 1 |
| 2026-03-30 | 8-K | FORM 8-K | 1.01,5.03,9.01 | 0001683168-26-002419 | 000-25553 | 26813426 | 34 | 368780 | 1 | 1 |
| 2026-03-05 | 8-K | CURRENT REPORT | 1.01,9.01 | 0001683168-26-001511 | 000-25553 | 26724397 | 34 | 524668 | 1 | 1 |
| 2026-03-04 | 8-K | CURRENT REPORT | 1.01,2.01,9.01 | 0001683168-26-001462 | 000-25553 | 26719212 | 34 | 236853 | 1 | 1 |
| 2026-02-18 | SC 14F1 | SCHEDULE 14F-1 | 0001683168-26-001159 | 005-78743 | 26647495 | 34 | 49871 | |||
| 2026-02-17 | 8-K | FORM 8-K | 1.01,3.02,5.01,5.02,9.01 | 0001683168-26-001055 | 000-25553 | 26636579 | 34 | 335694 | 1 | 1 |
| 2026-01-20 | 10-K | 10-K FOR DEC 2025 | 0001683168-26-000412 | 000-25553 | 26541951 | 34 | 2224701 | 1 | 1 | |
| 2025-10-20 | 10-Q | QUARTERLY REPORT | 0001683168-25-007656 | 000-25553 | 251402914 | 34 | 1682275 | 1 | 1 | |
| 2025-09-16 | 8-K | FORM 8-K | 8.01 | 0001683168-25-007032 | 000-25553 | 251317269 | 34 | 186933 | 1 | 1 |
| 2025-08-01 | 10-Q | FORM 10-Q FOR JUN 2025 | 0001683168-25-005573 | 000-25553 | 251175181 | 34 | 1583967 | 1 | 1 | |
| 2025-05-12 | 10-Q | QUARTERLY REPORT | 0001683168-25-003408 | 000-25553 | 25933883 | 34 | 1531061 | 1 | 1 | |
| 2025-03-11 | 8-A12G | FORM 8-A12G | 0001683168-25-001515 | 000-25553 | 25728354 | 34 | 20078 | |||
| 2025-03-03 | 10-K | FORM 10-K FOR 2024 | 0001683168-25-001303 | 000-25553 | 25696983 | 34 | 2676053 | 1 | 1 | |
| 2024-10-31 | 10-Q | FORM 10-Q FOR SEPTEMBER 2024 | 0001683168-24-007491 | 000-25553 | 241413669 | 34 | 2071203 | 1 | 1 | |
| 2024-10-30 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-10-30 16:00:00 | 9999999995-24-003315 | 333-276779 | 241412149 | 33 | 2031 | ||
| 2024-10-28 | CORRESP | filename1.htm | 0001683168-24-007410 | 6400 | ||||||
| 2024-10-04 | CORRESP | filename1.htm | 0001683168-24-006936 | 14221 | ||||||
| 2024-10-04 | S-1/A | AMENDMENT 12 TO FORM S-1 | 0001683168-24-006934 | 333-276779 | 241354590 | 33 | 1026873 | |||
| 2024-10-03 | UPLOAD | filename1.pdf | 0000000000-24-011196 | 333-276779 | 43440 | |||||
| 2024-09-25 | S-1/A | S-1/A | 0001683168-24-006629 | 333-276779 | 241321199 | 33 | 1026253 | |||
| 2024-09-24 | CORRESP | filename1.htm | 0001683168-24-006630 | 9249 | ||||||
| 2024-09-18 | 8-K | FORM 8-K | 4.02 | 0001683168-24-006484 | 000-25553 | 241307151 | 34 | 195827 | 1 | 1 |
| 2024-09-11 | UPLOAD | filename1.pdf | 0000000000-24-010268 | 333-276779 | 43227 | |||||
| 2024-08-29 | CORRESP | filename1.htm | 0001683168-24-006102 | 10229 | ||||||
| 2024-08-29 | S-1/A | S-1/A | 0001683168-24-006101 | 333-276779 | 241261767 | 33 | 911078 | |||
| 2024-08-23 | UPLOAD | filename1.pdf | 0000000000-24-009670 | 333-276779 | 43173 | |||||
| 2024-08-16 | S-1/A | AMENDMENT NO 9 | 0001683168-24-005785 | 333-276779 | 241213712 | 33 | 886001 | |||
| 2024-08-15 | CORRESP | filename1.htm | 0001683168-24-005787 | 9715 | ||||||
| 2024-08-14 | UPLOAD | filename1.pdf | 0000000000-24-009333 | 333-276779 | 42527 | |||||
| 2024-08-12 | 10-Q | QUARTERLY REPORT | 0001683168-24-005462 | 000-25553 | 241195334 | 34 | 1949522 | 1 | 1 | |
| 2024-08-06 | S-1/A | FORM S-1 AMENDMENT 8 | 0001683168-24-005290 | 333-276779 | 241178480 | 33 | 885586 | |||
| 2024-08-02 | CORRESP | filename1.htm | 0001683168-24-005244 | 16325 | ||||||
| 2024-08-02 | S-1/A | FROM S-1 AMENDMENT 7 | 0001683168-24-005243 | 333-276779 | 241172005 | 33 | 884455 | |||
| 2024-08-01 | UPLOAD | filename1.pdf | 0000000000-24-008797 | 333-276779 | 43562 | |||||
| 2024-07-24 | S-1/A | FROM S-1 AMENDMENT 6 | 0001683168-24-005020 | 333-276779 | 241136163 | 33 | 878187 | |||
| 2024-05-08 | 8-K | FORM 8-K | 4.01 | 0001683168-24-003098 | 000-25553 | 24925507 | 34 | 196113 | 1 | 1 |
| 2024-05-03 | CORRESP | filename1.htm | 0001683168-24-002958 | 6543 | ||||||
| 2024-05-02 | CORRESP | filename1.htm | 0001683168-24-002915 | 6256 | ||||||
| 2024-05-02 | CORRESP | filename1.htm | 0001683168-24-002905 | 6256 | ||||||
| 2024-04-22 | CORRESP | filename1.htm | 0001683168-24-002581 | 9209 | ||||||
| 2024-04-22 | S-1/A | FORM S-1 AMENDMENT 5 | 0001683168-24-002579 | 333-276779 | 24861347 | 33 | 695250 | |||
| 2024-04-19 | UPLOAD | filename1.pdf | 0000000000-24-004354 | 333-276779 | 43591 | |||||
| 2024-04-17 | CORRESP | filename1.htm | 0001683168-24-002494 | 10915 | ||||||
| 2024-04-17 | S-1/A | AMENDMENT NO 4 | 0001683168-24-002493 | 333-276779 | 24851297 | 33 | 696482 | |||
| 2024-04-17 | UPLOAD | filename1.pdf | 0000000000-24-004180 | 333-276779 | 43934 | |||||
| 2024-04-09 | S-1/A | FORM S-1 AMENDMENT 3 | 0001683168-24-002217 | 333-276779 | 24830684 | 33 | 696502 | |||
| 2024-04-08 | CORRESP | filename1.htm | 0001683168-24-002218 | 14632 | ||||||
| 2024-04-02 | UPLOAD | filename1.pdf | 0000000000-24-003518 | 333-276779 | 44510 | |||||
| 2024-03-22 | CORRESP | filename1.htm | 0001683168-24-001620 | 27711 | ||||||
| 2024-03-22 | S-1/A | AMENDMENT #2 TO S-1 | 0001683168-24-001617 | 333-276779 | 24773441 | 33 | 1095747 | |||
| 2024-03-18 | UPLOAD | filename1.pdf | 0000000000-24-002915 | 333-276779 | 48773 | |||||
| 2024-03-05 | S-1/A | AMENDMENT #1 TO FORM S-1 | 0001683168-24-001299 | 333-276779 | 24718025 | 33 | 996088 | |||
| 2024-03-04 | CORRESP | filename1.htm | 0001683168-24-001301 | 66251 | ||||||
| 2024-02-26 | UPLOAD | filename1.pdf | 0000000000-24-002115 | 333-276779 | 59643 | |||||
| 2024-01-31 | DEL AM | DELAYING REQUEST | 0001683168-24-000582 | 333-276779 | 24583673 | 33 | 5583 | |||
| 2024-01-30 | S-1 | S-1 | 0001683168-24-000556 | 333-276779 | 24582073 | 33 | 12116155 | |||
| 2006-08-02 | 10QSB/A | AMERSIN AMENDED Q3-05 A1 | 0001009919-06-000028 | 000-25553 | 06995888 | 34 | 5653175 | |||
| 2006-08-02 | 10QSB/A | AMERSIN AMENDED Q2-05 A1 | 0001009919-06-000026 | 000-25553 | 06995880 | 34 | 5562978 | |||
| 2006-08-02 | 10QSB/A | AMERSIN 10QSB/A Q1-05 A1 | 0001009919-06-000024 | 000-25553 | 06995852 | 34 | 5412387 | |||
| 2006-07-27 | 10KSB/A | AMERSIN AMENDED(1) 10KSB FOR YEAR ENDED 01-31-06 | 0001009919-06-000022 | 000-25553 | 06983447 | 34 | 4595849 | |||
| 2006-07-11 | UPLOAD | filename1.pdf | 0000000000-06-032171 | 34226 | ||||||
| 2006-07-10 | 8-K | AMERSIN FORM 8-K ITEM 4.02 | 4.02 | 0001009919-06-000019 | 000-25553 | 06954352 | 34 | 16252 | ||
| 2006-06-15 | NT 10-Q | AMERSIN FORM 12B-25 LATE FILING NOTICE Q1-2006 | 0001009919-06-000017 | 000-25553 | 06907688 | 34 | 18286 | |||
| 2006-06-15 | 15-12G | AMERSIN FROM 15-12G | 0001009919-06-000014 | 000-25553 | 06907569 | 34 | 9444 | |||
| 2006-06-14 | 10KSB | AMERSIN 10KSB - JANUARY 31ST, 2006 | 0001009919-06-000012 | 000-25553 | 06903956 | 34 | 8574307 | |||
| 2006-06-13 | 5 | PRIMARY DOCUMENT | 0001140905-06-000082 | 4584 | ||||||
| 2006-06-13 | 5 | PRIMARY DOCUMENT | 0001140905-06-000081 | 6791 | ||||||
| 2006-06-13 | 5 | PRIMARY DOCUMENT | 0001140905-06-000080 | 4613 | ||||||
| 2006-06-13 | 5 | PRIMARY DOCUMENT | 0001140905-06-000079 | 4572 | ||||||
| 2006-05-02 | NTN 10Q | AMERSIN LATE FILING NOTIFICATION | 0001009919-06-000007 | 000-25553 | 06797499 | 34 | 18343 | |||
| 2006-02-16 | 5 | PRIMARY DOCUMENT | 0001009919-06-000005 | 4486 | ||||||
| 2006-01-17 | 10QSB | AMERSIN THIRD QUARTER REPORT - OCTOBER 31ST, 2005 | 0001009919-06-000002 | 000-25553 | 06531932 | 34 | 6535015 | |||
| 2005-12-27 | 8-K/A | AMENDMENT TO FORM 8-K ITEM 4.02 FILED 14DEC05 | 4.02 | 0001009919-05-000046 | 000-25553 | 051286909 | 34 | 18310 | ||
| 2005-12-27 | CORRESP | filename1.htm | 0001009919-05-000044 | 8509 | ||||||
| 2005-12-21 | UPLOAD | filename1.txt | 0000000000-05-063244 | 5003 | ||||||
| 2005-12-14 | NT 10-Q | AMERSIN FORM 12B25 NT-10QSB Q3 | 0001009919-05-000040 | 000-25553 | 051263397 | 34 | 18572 | |||
| 2005-12-14 | 8-K | AMERSIN FORM 8-K ITEM 4.02 | 4.02 | 0001009919-05-000038 | 000-25553 | 051263378 | 34 | 17543 | ||
| 2005-11-17 | 8-K | AMERSIN - FORM 8K, APPOINTMENT OF DIRECTOR | 5.02 | 0001009919-05-000036 | 000-25553 | 051211953 | 34 | 20975 | ||
| 2005-11-16 | 8-K | AMERSIN LIFE SCIENCES 8-K ITEM 5.02 RESIGNATION | 5.02 | 0001009919-05-000034 | 000-25553 | 051207762 | 34 | 15380 | ||
| 2005-10-20 | 8-K | AMERSIN LIFE SCIENCES CORPORATION FORM 8-K ITEM 2.01 | 2.01 | 0001009919-05-000032 | 000-25553 | 051147436 | 34 | 21916 | ||
| 2005-10-20 | 10QSB | AMERSIN LIFE SCIENCES QUARTERLY REPORT - JULY 31ST, 2005 | 0001009919-05-000030 | 000-25553 | 051146862 | 34 | 6330496 | |||
| 2005-09-16 | NTN 10Q | f050915form12b25.htm | 0001009919-05-000021 | 000-25553 | 051087539 | 34 | 18464 | |||
| 2005-09-16 | 8-K | f050915amls8k.htm | 1.02 | 0001009919-05-000019 | 000-25553 | 051087526 | 34 | 19237 | ||
| 2005-06-21 | 10QSB | AMERSIN LIFE SCIENCES QUARTERLY REPORT Q1-05 | 0001009919-05-000015 | 000-25553 | 05907115 | 34 | 2067802 | |||
| 2005-06-15 | NT 10-Q | NOTICE OF LATE FILING FOR 1ST QUARTER ENDED 30APR05 | 0001009919-05-000012 | 000-25553 | 05896624 | 34 | 17915 | |||
| 2005-06-02 | 10KSB | AMERSIN LIFE SCIENCES CORPORATION ANNUAL REPORT | 0001009919-05-000010 | 000-25553 | 05872975 | 34 | 2067028 | |||
| 2005-05-18 | 8-K | AMERSIN ANNOUNCES DELAY IN FILING ANNUAL REPORT DUE TO AUDITOR???S WORKLOAD | 8.01 | 0001009919-05-000007 | 000-25553 | 05841265 | 34 | 401768 | ||
| 2005-05-13 | 5 | PRIMARY DOCUMENT | 0001140905-05-000063 | 4541 | ||||||
| 2005-05-13 | 5 | PRIMARY DOCUMENT | 0001140905-05-000062 | 4581 | ||||||
| 2005-05-13 | 5 | PRIMARY DOCUMENT | 0001140905-05-000061 | 7456 | ||||||
| 2005-05-13 | 5 | PRIMARY DOCUMENT | 0001140905-05-000060 | 4554 | ||||||
| 2005-05-02 | NT 10-K | doc1.htm | 0001140361-05-003332 | 000-25553 | 05791684 | 34 | 11925 | |||
| 2005-04-21 | 4 | PRIMARY DOCUMENT | 0001276310-05-000002 | 5020 | ||||||
| 2005-04-06 | 8-K | AMERSIN LIFE SCIENCES 8-K 4-6-2005 | 8.01 | 0001015402-05-001743 | 000-25553 | 05735865 | 34 | 32666 | ||
| 2005-04-05 | 8-K | AMERISIN LIFE SCIENCE CORP. 8-K 3-8-2005 | 2.02 | 0001015402-05-001731 | 000-25553 | 05734184 | 34 | 41269 | ||
| 2005-03-02 | 8-K | HUBEI PHARAMACEUTICALS 8-K 03-01-2005 | 5.02 | 0001015402-05-001016 | 000-25553 | 05651798 | 34 | 8443 | ||
| 2005-01-31 | 5 | PRIMARY DOCUMENT | 0001276310-05-000001 | 12178 | ||||||
| 2005-01-14 | 8-K | HUBEI PHARMACEUTICAL GROUP 8-K 1-6-2005 | 5.03,8.01 | 0001015402-05-000155 | 000-25553 | 05529684 | 34 | 35265 | ||
| 2005-01-14 | 10KSB/A | HUBEI PHARMACEUTICAL 10KSBA 01-31-2004 | 0001015402-05-000153 | 000-25553 | 05529345 | 34 | 44259 | |||
| 2004-12-15 | DEF 14C | HUBEI PHARMACEUTICAL GROUP, LTD. DEF 14C 12-10-2004 | 0001015402-04-005425 | 000-25553 | 041202970 | 34 | 81768 | |||
| 2004-12-13 | 10QSB | HUBEI PHARMACEUTICAL 10QSB 10-31-2004 | 0001015402-04-005372 | 000-25553 | 041197761 | 34 | 787510 | |||
| 2004-11-24 | 8-K | HUBEI 8-K 11-18-2004 | 5.03 | 0001015402-04-005200 | 000-25553 | 041167870 | 34 | 24281 | ||
| 2004-11-19 | PRE 14C | HUBEI PRE 14C 12-10-2004 | 0001015402-04-005088 | 000-25553 | 041156408 | 34 | 83334 | |||
| 2004-09-27 | REGDEX | AUTO-GENERATED PAPER DOCUMENT | 06 | 9999999997-04-038681 | 021-69684 | 04043932 | 1812 | |||
| 2004-09-23 | 8-K | FORM 8-K FILING DOCUMENT | 2.02 | 0001171843-04-000297 | 000-25553 | 041042922 | 15576 | |||
| 2004-09-22 | 10QSB | HUBEI PHARMACEUTICAL 10QSB 07-31-2004 | 0001015402-04-003946 | 000-25553 | 041040390 | 872575 | ||||
| 2004-09-14 | 8-K | HUBEI PHARMACEUTICAL FORM 8-K FOR EVENTS DATED SEPTEMBER 10, 2004 | 1.01,9.01 | 0001015402-04-003854 | 000-25553 | 041029049 | 38468 | |||
| 2004-09-14 | NT 10-Q | doc1.htm | 0001140361-04-005253 | 000-25553 | 041028605 | 10654 | ||||
| 2004-09-07 | 8-K | HUBEI PHARMACEUTICAL GROUP LTD. FORM 8-K FOR EVENTS REPORTED JULY 9, 2004 | 2.01,9.01 | 0001015402-04-003764 | 000-25553 | 041018507 | 522682 | |||
| 2004-07-22 | 4 | PRIMARY DOCUMENT | 0001276310-04-000005 | 9393 | ||||||
| 2004-07-12 | 10KSB/A | doc1.txt | 0001015402-04-002891 | 000-25553 | 04909672 | 6750 | ||||
| 2004-06-22 | 10QSB | doc1.txt | 0001015402-04-002658 | 000-25553 | 04873386 | 115043 | ||||
| 2004-06-15 | NT 10-Q | doc1.htm | 0001140361-04-003652 | 000-25553 | 04862998 | 10014 | ||||
| 2004-05-17 | 10KSB | doc1.txt | 0001015402-04-002182 | 000-25553 | 04812777 | 179299 | ||||
| 2004-05-17 | SC 13D | kris13d.htm | 0001288425-04-000001 | 005-78743 | 04809403 | 41816 | ||||
| 2004-05-17 | SC 13D | jing13d.htm | 0001288426-04-000002 | 005-78743 | 04809402 | 41621 | ||||
| 2004-05-17 | SC 13D | liang13d.htm | 0001288427-04-000001 | 005-78743 | 04809398 | 41641 | ||||
| 2004-05-12 | 3 | PRIMARY DOCUMENT | 0001288426-04-000001 | 4113 | ||||||
| 2004-05-03 | NT 10-K | doc1.htm | 0001140361-04-002839 | 000-25553 | 04772073 | 9957 | ||||
| 2004-04-20 | 5 | PRIMARY DOCUMENT | 0001286998-04-000001 | 7376 | ||||||
| 2004-04-07 | 8-K | doc1.txt | 5,6 | 0001015402-04-001385 | 000-25553 | 04721474 | 7631 | |||
| 2004-03-12 | 8-K | doc1.txt | 12 | 0001015402-04-000936 | 000-25553 | 04664374 | 5772 | |||
| 2004-03-09 | 5/A | PRIMARY DOCUMENT | 0001276310-04-000003 | 6337 | ||||||
| 2004-03-09 | 5 | PRIMARY DOCUMENT | 0001276310-04-000002 | 6260 | ||||||
| 2004-03-09 | 3 | PRIMARY DOCUMENT | 0001276310-04-000001 | 5555 | ||||||
| 2003-12-16 | 10QSB | doc1.txt | 0001015402-03-004981 | 000-25553 | 031056187 | 112196 | ||||
| 2003-12-09 | S-8 | hubeiesop.htm | 0001140905-03-000089 | 333-111023 | 031044338 | 232689 | ||||
| 2003-10-28 | 8-K | doc1.txt | 1,6 | 0001015402-03-004213 | 000-25553 | 03959878 | 8567 | |||
| 2003-10-10 | 8-K/A | HUBEI 8-KA 6-27-2003 | 4 | 0001015402-03-004047 | 000-25553 | 03936774 | 44705 | |||
| 2003-10-10 | 8-K/A | doc1.txt | 4,5 | 0001015402-03-004041 | 000-25553 | 03936189 | 11161 | |||
| 2003-10-09 | 10QSB | doc1.txt | 0001015402-03-004029 | 000-25553 | 03934182 | 137339 | ||||
| 2003-10-01 | 8-K/A | doc1.txt | 4,5 | 0001015402-03-003972 | 000-25553 | 03919101 | 11161 | |||
| 2003-09-16 | NT 10-Q | doc1.htm | 0001140361-03-003348 | 000-25553 | 03896459 | 9979 | ||||
| 2003-09-04 | 8-K | doc1.txt | 2,4,5 | 0001015402-03-003690 | 000-25553 | 03880981 | 8639 | |||
| 2003-08-29 | S-8 | hubeis8.htm | 0001140905-03-000069 | 333-108358 | 03873165 | 36578 | ||||
| 2003-06-25 | 8-K | doc1.txt | 5 | 0001015402-03-002506 | 000-25553 | 03755742 | 10664 | |||
| 2003-06-25 | 10QSB | doc1.txt | 0001015402-03-002504 | 000-25553 | 03755660 | 35079 | ||||
| 2003-06-13 | NT 10-Q | doc1.htm | 0001140361-03-002021 | 000-25553 | 03742975 | 9975 | ||||
| 2003-05-15 | 10KSB | doc1.txt | 0001015402-03-001838 | 000-25553 | 03700574 | 81206 | ||||
| 2003-04-30 | NT 10-K | doc1.htm | 0001140361-03-001253 | 000-25553 | 03674150 | 9548 | ||||
| 2003-04-10 | 8-K | doc1.txt | 6,7 | 0001015402-03-001142 | 000-25553 | 03644537 | 18593 | |||
| 2003-03-20 | SC 13D | doc1.txt | 0001015402-03-000788 | 005-78743 | 03610949 | 13654 | ||||
| 2003-03-12 | 8-K | doc1.txt | 5,7 | 0001015402-03-000699 | 000-25553 | 03600635 | 6855 | |||
| 2003-03-10 | S-8 | doc1.txt | 0001015402-03-000679 | 333-103731 | 03598991 | 27346 | ||||
| 2003-02-11 | SC 13D | PAN ASIA SCHEDULE 13D | 0001015402-03-000288 | 005-78743 | 03549704 | 14209 | ||||
| 2003-02-07 | 8-K | doc1.txt | 1 | 0001015402-03-000267 | 000-25553 | 03545381 | 6899 | |||
| 2003-02-07 | SC 13D | doc1.txt | 0001015402-03-000263 | 005-78743 | 03545007 | 22121 | ||||
| 2003-02-04 | 8-K | doc1.txt | 1,7 | 0001015402-03-000219 | 000-25553 | 03537814 | 11647 | |||
| 2002-12-19 | 10QSB | doc1.txt | 0001015402-02-004090 | 000-25553 | 02863465 | 21446 | ||||
| 2002-12-16 | NT 10-Q | doc1.htm | 0001140361-02-000831 | 000-25553 | 02859176 | 9388 | ||||
| 2002-12-10 | 8-K | doc1.txt | 1,6 | 0001015402-02-004048 | 000-25553 | 02853350 | 6510 | |||
| 2002-09-23 | 10QSB | form10qsb.txt | 0001062993-02-000479 | 000-25553 | 02769690 | 21817 | ||||
| 2002-09-23 | 8-K | form8k.txt | 2,7 | 0001062993-02-000477 | 000-25553 | 02769682 | 9502 | |||
| 2002-09-16 | NT 10-Q | formnt10q.htm | 0001062993-02-000448 | 000-25553 | 02764539 | 9812 | ||||
| 2002-06-25 | 10QSB | FORM 10-QSB FOR THE PERIOD ENDED 4/30/2002 | 0001032210-02-001011 | 000-25553 | 02686366 | 113374 | ||||
| 2002-06-18 | S-8 POS | extls8a.htm | 0001096295-02-000003 | 333-89762 | 02681241 | 34110 | ||||
| 2002-06-14 | S-8 POS | extls8a.htm | 0001140905-02-000037 | 333-89762 | 02678677 | 34110 | ||||
| 2002-06-04 | S-8 | extls859.htm | 0001140905-02-000036 | 333-89762 | 02670120 | 34010 | ||||
| 2002-05-28 | 8-K/A | extl8ka.htm | 2 | 0001140905-02-000033 | 000-25553 | 02663164 | 23745 | |||
| 2002-05-28 | 8-K | extl8k2.htm | 2 | 0001140905-02-000032 | 000-25553 | 02663147 | 13497 | |||
| 2002-05-15 | 8-K | extl8k.htm | 2 | 0001140905-02-000022 | 000-25553 | 02651308 | 30010 | |||
| 2002-04-30 | 10KSB | doc1.txt | 0001015402-02-001478 | 000-25553 | 02627506 | 46412 | ||||
| 2001-12-13 | 10QSB | FORM 10QSB FOR PERIOD ENDED OCTOBER 31, 2001. | 0001032210-01-501482 | 000-25553 | 1813174 | 19819 | ||||
| 2001-09-14 | 10QSB | FORM 10QSB FOR PERIOD ENDED JULY 31, 2001. | 0001032210-01-501089 | 000-25553 | 1737424 | 19648 | ||||
| 2001-07-24 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001032210-01-500869 | 000-25553 | 1686696 | 86814 | ||||
| 2001-06-20 | PRE 14A | PRELIMINARY PROXY STATEMENT | 0001032210-01-500704 | 000-25553 | 1664047 | 86251 | ||||
| 2001-06-15 | 10QSB | FORM 10QSB FOR PERIOD ENDED APRIL, 30, 2001 | 0001032210-01-500691 | 000-25553 | 1661704 | 18811 | ||||
| 2001-04-30 | 10KSB | FORM 10KSB FOR THE FISCAL YEAR ENDED 01/31/2001 | 0001032210-01-500434 | 000-25553 | 1616254 | 49082 | ||||
| 2000-12-12 | 10QSB | FORM 10-QSB FOR THE PERIOD ENDING 10/31/2000 | 0001032210-00-002342 | 000-25553 | 787776 | 111079 | ||||
| 2000-12-12 | 8-K | FORM 8-K | 2,6,7 | 0001032210-00-002341 | 000-25553 | 787770 | 89908 | |||
| 2000-09-13 | 10QSB | FORM 10QSB FOR THE PERIOD ENDED 07/31/2000 | 0001032210-00-001863 | 000-25553 | 721639 | 52746 | ||||
| 2000-09-11 | 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 2,5,6,7 | 0001032210-00-001850 | 000-25553 | 720681 | 26037 | |||
| 2000-09-08 | 8-K | FORM 8-K | 2,5,6,7 | 0001032210-00-001843 | 000-25553 | 719576 | 5958 | |||
| 2000-06-19 | 10QSB | 0001.txt | 0001062993-00-000078 | 000-25553 | 657200 | 34644 | ||||
| 2000-06-19 | 10-Q | 0001.txt | 0001062993-00-000077 | 000-25553 | 657152 | 34641 | ||||
| 2000-06-14 | NT 10-Q | 0001.txt | 0001062993-00-000074 | 000-25553 | 654736 | 6073 | ||||
| 2000-06-08 | 8-K | 0001.txt | 2,6,7 | 0001075793-00-000059 | 000-25553 | 651603 | 92414 | |||
| 2000-05-12 | 10KSB | 0001062993-00-000059 | 0001062993-00-000059 | 000-25553 | 627951 | 59078 | ||||
| 2000-04-28 | NTN 10K | 0001075793-00-000038 | 0001075793-00-000038 | 000-25553 | 612324 | 5132 | ||||
| 1999-12-14 | 10QSB | 0001062993-99-000053 | 0001062993-99-000053 | 000-25553 | 99774107 | 27136 | ||||
| 1999-09-20 | 10QSB | 0001075793-99-000034 | 0001075793-99-000034 | 000-25553 | 99713705 | 22844 | ||||
| 1999-07-13 | 10SB12G/A | 0001075793-99-000015 | 0001075793-99-000015 | 000-25553 | 99663187 | 94269 | ||||
| 1999-07-13 | 10QSB | 0001075793-99-000014 | 0001075793-99-000014 | 000-25553 | 99663185 | 22155 | ||||
| 1999-05-27 | 10SB12G/A | 0001075793-99-000010 | 0001075793-99-000010 | 000-25553 | 99635879 | 62885 | ||||
| 1999-03-12 | 10SB12G | 0001075793-99-000003 | 0001075793-99-000003 | 000-25553 | 99563954 | 225375 |
One latest value per concept from companyfacts (81 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 115.89M | 2026-11-18 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 0 | 2025-06-30 | 2025 | FY | 10-K | 2026-01-20 | 0001683168-26-000412 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 29,099 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 5,391 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 965,964 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | AdjustmentForAmortization | Amortization | USD | 20,984 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | 48,603 | 2026-01-01 | 2026-03-31 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 20,984 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | Assets | Assets | USD | 559,712 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 63,696 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | Cash | Cash | USD | 46 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 46 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 46 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 0 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001683168-26-003707 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 115.89M | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 115.89M | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 115,894 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 12,180 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-01-20 | 0001683168-26-000412 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 85,376 | 2024-11-21 | 2024-11-22 | 2025 | FY | 10-K | 2026-01-20 | 0001683168-26-000412 |
| us-gaap | DebtConversionConvertedInstrumentSharesIssued1 | Debt Conversion, Converted Instrument, Shares Issued | shares | 90.00M | 2024-11-21 | 2024-11-22 | 2025 | FY | 10-K | 2026-01-20 | 0001683168-26-000412 |
| us-gaap | DebtInstrumentDecreaseForgiveness | Debt Instrument, Decrease, Forgiveness | USD | 4,443 | 2025-09-10 | 2025-09-11 | 2025 | FY | 10-K | 2026-01-20 | 0001683168-26-000412 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001683168-25-001303 |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 76,680 | 2025-12-31 | 2025 | FY | 10-K | 2026-01-20 | 0001683168-26-000412 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-01-20 | 0001683168-26-000412 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 76,680 | 2025-12-31 | 2025 | FY | 10-K | 2026-01-20 | 0001683168-26-000412 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 76,680 | 2025-12-31 | 2025 | FY | 10-K | 2026-01-20 | 0001683168-26-000412 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.002 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.002 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001683168-25-001303 |
| us-gaap | FederalIncomeTaxExpenseBenefitContinuingOperations | Federal Income Tax Expense (Benefit), Continuing Operations | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-01-20 | 0001683168-26-000412 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 66,773 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001683168-26-003707 |
| us-gaap | GrossProfit | Gross Profit | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -119,313 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001683168-26-003707 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001683168-26-003707 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001683168-26-003707 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 29,099 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 62,150 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | IntangibleAssetsGrossExcludingGoodwill | Intangible Assets, Gross (Excluding Goodwill) | USD | 225,000 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 450,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001683168-26-003707 | |
| us-gaap | InterestExpense | Interest Expense | USD | 864 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001683168-26-003707 |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 145,182 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | Liabilities | Liabilities | USD | 54,944 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 559,712 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 54,944 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 10,635 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001683168-26-006245 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -10,589 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -212,307 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Integer | 1 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Integer | 1 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 190,459 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -190,459 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 496,016 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -21,848 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001683168-26-006245 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 5.00M | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 300,000 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 300,000 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 300 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 63,650 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 48,439 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001683168-25-001303 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 39,600 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001683168-26-003707 |
| us-gaap | ProceedsFromRepaymentsOfRelatedPartyDebt | Proceeds from (Repayments of) Related Party Debt | USD | -37,804 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | ProfessionalAndContractServicesExpense | Professional and Contract Services Expense | USD | 52,540 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001683168-26-003707 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -577,390 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | Revenues | Revenues | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 504,768 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 | |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 92,550 | 2026-04-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 48,439 | 2026-04-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 85,376 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-01-20 | 0001683168-26-000412 |
| us-gaap | StockIssuedDuringPeriodValuePurchaseOfAssets | Stock Issued During Period, Value, Purchase of Assets | USD | 517,000 | 2026-04-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | StockRedeemedOrCalledDuringPeriodValue | Stock Redeemed or Called During Period, Value | USD | 0 | 2023-01-01 | 2023-03-31 | 2024 | Q3 | 10-Q | 2024-10-31 | 0001683168-24-007491 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 106.79M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 106.79M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-18 | 0001683168-26-008922 |